Unraveling the role of Ctla-4 in intestinal immune homeostasis through a novel Zebrafish model of inflammatory bowel disease
eLife · 2025
DOI: 10.7554/elife.101932 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Lulu Qin und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Key Laboratory for Cell and Gene Engineering of Zhejiang Province, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Zebrafish, Inflammatory Bowel Diseases, CTLA-4 Antigen, Homeostasis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is a chronic and relapsing immune-mediated disorder characterized by intestinal inflammation and epithelial injury. The underlying causes of IBD are not fully understood, but genetic factors have been implicated in genome-wide association studies, including CTLA-4, an essential negative regulator of T cell activation. However, establishing a direct link between CTLA-4 and IBD has been challenging due to the early lethality of CTLA-4 knockout mice. In this study, we identified zebrafish Ctla-4 homolog and investigated its role in maintaining intestinal immune homeostasis by generating a Ctla-4-deficient ( ctla-4 -/- ) zebrafish line. These mutant zebrafish exhibited reduced weight, along with impaired epithelial barrier integrity and lymphocytic infiltration in their intestines. Transcriptomics analysis revealed upregulation of inflammation-related genes, disturbing immune system homeostasis. Moreover, single-cell RNA-sequencing analysis indicated increased Th2 cells and interleukin 13 expression, along with decreased innate lymphoid cells and upregulated proinflammatory cytokines. Additionally, Ctla-4-deficient zebrafish exhibited reduced diversity and an altered composition of the intestinal microbiota. All these phenotypes closely resemble those found in mammalian IBD. Lastly, supplementation with Ctla-4-Ig successfully alleviated intestinal inflammation in these mutants. Altogether, our findings demonstrate the pivotal role of Ctla-4 in maintaining intestinal homeostasis. Additionally, they offer substantial evidence linking CTLA-4 to IBD and establish a novel zebrafish model for investigating both the pathogenesis and potential treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Sciences, Key Laboratory for Cell and Gene Engineering of Zhejiang Province, Zhejiang University, Hangzhou, China.
- Department of Genetic and Metabolic Disease, the Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
- Laboratory for Marine Biology and Biotechnology, Qingdao National Laboratory for Marine Science and Technology, Qingdao, China.
ORCID-Profile: Lulu Qin, Chongbin Hu, Ye Chen, Jianzhong Shao
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Qin, L., Hu, C., Zhao, Q., Wang, Y., Fan, D., Lin, A., Xiang, L., Chen, Y., & Shao, J. (2025). Unraveling the role of Ctla-4 in intestinal immune homeostasis through a novel Zebrafish model of inflammatory bowel disease. eLife. https://doi.org/10.7554/elife.101932
Vancouver
Qin L, Hu C, Zhao Q, Wang Y, Fan D, Lin A, et al. Unraveling the role of Ctla-4 in intestinal immune homeostasis through a novel Zebrafish model of inflammatory bowel disease. eLife. 2025. doi:10.7554/elife.101932
BibTeX
@article{Qin2025,
author = {Qin, Lulu and Hu, Chongbin and Zhao, Qiong and Wang, Yong and Fan, Dongdong and Lin, Aifu and Xiang, Lixin and Chen, Ye and Shao, Jianzhong},
title = {Unraveling the role of Ctla-4 in intestinal immune homeostasis through a novel Zebrafish model of inflammatory bowel disease},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.101932}
}
EUVIMED